RAPHE PHARMACEUTIQUE LABORATORIE Trademark

Trademark Overview

On Tuesday, February 28, 2023, a trademark application was filed for RAPHE PHARMACEUTIQUE LABORATORIE with the United States Patent and Trademark Office. The USPTO has given the RAPHE PHARMACEUTIQUE LABORATORIE trademark a serial number of 97816115. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 17, 2025. This trademark is owned by Eze, IjYahu Raphe. The RAPHE PHARMACEUTIQUE LABORATORIE trademark is filed in the Treatment & Processing of Materials Services category with the following description:

Custom manufacture of over the counter drug products by pharmaceutical compounders
raphe pharmaceutique laboratorie

General Information

Serial Number97816115
Word MarkRAPHE PHARMACEUTIQUE LABORATORIE
Filing DateTuesday, February 28, 2023
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 17, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2024

Trademark Statements

Goods and ServicesCustom manufacture of over the counter drug products by pharmaceutical compounders
Translation of Words in MarkThe English translation of PHARMACEUTIQUE in the mark is PHARMACEUTICAL.
NOT AVAILABLE"PHARMACEUTIQUE LABORATORY"

Classification Information

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateMonday, December 11, 2023
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEze, IjYahu Raphe
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDALLAS, TX 75243
Party NameEze, IjYahu Raphe
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDALLAS, TX 75243

Trademark Events

Event DateEvent Description
Friday, March 3, 2023NEW APPLICATION ENTERED
Monday, March 20, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 28, 2023ASSIGNED TO EXAMINER
Monday, December 11, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, December 11, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, December 11, 2023REMOVED FROM TEAS PLUS
Monday, December 11, 2023NON-FINAL ACTION WRITTEN
Monday, December 11, 2023NON-FINAL ACTION E-MAILED
Monday, December 11, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 12, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, April 25, 2024EXAMINERS AMENDMENT -WRITTEN
Thursday, April 25, 2024EXAMINERS AMENDMENT E-MAILED
Thursday, April 25, 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, April 25, 2024EXAMINER'S AMENDMENT ENTERED
Wednesday, May 15, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 18, 2024PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 13, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Monday, March 17, 2025ABANDONMENT - NO USE STATEMENT FILED
Monday, March 17, 2025ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

laboratorie pharmaceutique raphe products pharmaceutical compounders drug counter manufacture over custom